Iconix Retrofits UC Berkeley Financial Data Algorithm for Chemogenomics Analysis | GenomeWeb

Iconix Pharmaceuticals, a Mountain View, Calif., chemogenomics company, has been happily compiling a database of chemical compounds and gene expression profiles for the past three years. But by the time the database, called DrugMatrix, began creeping toward 100 million data points a year ago, it was simply too large for Iconix’s researchers to extract meaningful information from it using standard data-mining tools, according to COO Leslie Browne.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.